Immunogenic compositions for use in pneumococcal vaccines
AssigneePfizer Inc.
InventorsAnnaliesa Sybil Anderson, Seema Shridhar Gangolli, Kathrin Ute Jansen, Avvari Krishna Prasad, Michael William Pride, Ingrid Lea Scully, Wendy Jo Watson
Life of this patent
Estimating the term…
Abstract
An object of the present invention is to provide immunogenic compositions for protection against S. pneumoniae, in particular against S. pneumoniae serogroup 15, while limiting the number of conjugates. The present invention therefore relates to new immunogenic compositions for use in pneumococcal vaccines and to vaccination of human subjects, in particular infants and elderly, against pneumococcal infections using said immunogenic compositions.
Claims24
-12. (canceled)
An immunogenic composition comprising glycoconjugates comprising capsular polysaccharide from S. pneumoniae serotype 15B and serotype 15A conjugated to a carrier protein, wherein said immunogenic composition does not comprise capsular polysaccharide from S. pneumoniae serotype 15C.
Dependencies are inferred from the claim text.